SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease
March 18, 2024 03:00 ET
|
Senisca Ltd
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease £3.7 million seed financing supported by consortium of new and...